Cite

HARVARD Citation

    David, M. et al. (2022). New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease. Annals of clinical and translational neurology. 9 (4), pp. 582-596. [Online]. 
  
Back to record